Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer.

Ke-Ren Zhang Yu-Fei Zhang Hui-Min Lei Ya-Bin TangChun-Shuang MaQian-Ming LvShi-Yi WangLi-Ming Lu Ying Shen Hong-Zhuan Chen Liang Zhu

Published in: Science translational medicine (2021)

[Figure: see text].

Keyphrases